3.2M DOSES.This undated photo shows a nurse preparing a Covid-19 vaccine shot to be administered at Project Balik Buhay in Cebu City. DOH-7 chief pathologist Dr. Mary Jean Loreche on Tuesday (Oct. 26, 2021) said the Central Visayas region already administered about 3.2 million Covid-19 vaccine doses.(PNA file photo by John Rey Saavedra) CEBU CITY - The Central Visayas region has administered a total of 3.2 million doses of coronavirus disease 2019 (Covid-19) vaccine seven months since the start of the national vaccination rollout in March, a Department of Health (DOH)-Region 7 official said on Tuesday. Dr. Mary Jean Loreche, DOH-7 chief pathologist, said the actual number of vaccine doses given to eligible population in the region was pegged at 3,270,115. Of the number, 1,716,049 were given as the first dose while 1,554,066 for the second dose, she added. About 73 percent of the total number of Covid-19 vaccine doses administered or 2,381,752 were given to the residents of the province
cars to go to work or taking the kids to school they are not thinking about art, sculptures, landscaping or high-speed rail in nancy pelosi s backyard when they think of infrastructure and that is the problem. democrats had to rename the package multiple times to sell it to the american people. don t care if you re republican or democrat you don t want the government to waste your money in this way. neil: sanders said don t overthink it. what will this do to our future if it gets passed? the way we are going with inflation we will see the worst inflation since world war ii. inflation is taxation. we ve seen groceries go up 21%, gas prices are up for me one dollar a gallon since the first of the year. lumber is up 381%, the cost of all houses go up by 30%. as this starts to hurt the
Balaxi Pharmaceuticals reports a PAT of INR 381 million for FY21; further strengthens the Product Pipeline
HYDERABAD, India, May 24, 2021 /PRNewswire/ Balaxi Pharmaceuticals Limited (Balaxi), a branded IPR-based pharmaceutical company headquartered in Hyderabad, reported its results for the quarter and year ended 31st March 2021.
Financial Highlights - Q4 & FY21:
16.5%
The Company recorded a revenue of INR 530 million for Q4F21, the drop in revenue in the fourth quarter is normal as China is shut down for most of the quarter due to the Chinese New Year holiday.
EBITDA of INR 100 million for Q4FY21; EBITDA margin stood at 18.9%.
Reported PAT of INR 84 million for Q4FY21.
BBCNEWS BBC News March 31, 2020 19:30:15 archive.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from archive.org Daily Mail and Mail on Sunday newspapers.
BBCNEWS The Papers March 31, 2020 22:31:15 archive.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from archive.org Daily Mail and Mail on Sunday newspapers.